Course of disease, drug treatment and health-related quality of life in patients with inflammatory bowel disease 5 years after initial diagnosis

European Journal of Gastroenterology and Hepatology

Volumn 17, Issue 10, 2005, Pages 1037-1045

  Bernklev, Tomm ^a,b,i   Jahnsen, Jørgen ^c   Schulz, Tom ^d   Sauar, Jostein ^e   Lygren, Idar ^f   Henriksen, Magne ^b   Stray, Njål ^g   Kjellevold, Øystein ^h   Aadland, Erling ^c   Vatn, Morten ^a   Moum, Bjørn ^b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b Østfold Hospital   (Norway)

^c AKER UNIVERSITY HOSPITAL   (Norway)

^d Sorlandet Hospital   (Norway)

^e TELEMARK HOSPITAL   (Norway)

^f ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^g DIAKONHJEMMET HOSPITAL   (Norway)

^h Telemark Hospital   (Norway)

ⁱ NONE   (Norway)

Author keywords

Course of disease; Drug treatment; Health related quality of life (HRQOL); Inflammatory bowel disease (IBD); Inflammatory bowel disease questionnaire (IBDQ); Regression analysis

Indexed keywords

AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; MESALAZINE; STEROID;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CROHN DISEASE; DISEASE COURSE; ENTERITIS; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RELAPSE; SCORING SYSTEM; STEROID THERAPY; ULCERATIVE COLITIS;

EID: 26444529476     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200510000-00006     Document Type: Article

References (33)

1. Drossman DA, Patrick DL, Mitchell CM, Zagami EW, Appelbaum MI. Health related quality of life in inflammatory bowel disease: functional status and patients' worries and concerns. Dig Dis Sci 1989; 34:1379-1386.
2. Guyatt G, Mitchell A, Irvine EJ, Singer J, Williams N, Goodacre R, Tompkins C. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989; 96:804-810.
3. Irvine EJ, Feagan B, Rochon J, Archambault A, Fedorak RN, Groll A, et al. Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group. Gastroenterology 1994; 106:287-296.
4. Love JR, Irvine EJ, Fedorak RN. Quality of life in inflammatory bowel disease. J Clin Gastroenterol 1992; 14:15-19.
5. Bernklev T, Mourn B, Mourn T, and the Inflammatory Bowel South-Eastern Norway (IBSEN) Group of Gastroenterologists. Quality of life in patients with inflammatory bowel disease: translation, data quality, scaling assumptions, validity, reliability and sensitivity to change of the Norwegian version of IBDQ. Scand J Gastroenterol 2002; 37:1164-1174.
6. Moum B, Vatn MH, Ekbom A, Aadland E, Fausa O, Lygren I, et al. Incidence of ulcerative colitis and indeterminate colitis in four counties of south-eastern Norway, 1990-1993. A prospective population-based study. Scand J Gastroenterol 1996; 31:362-366.
7. Moum B, Vatn MH, Ekbom A, Aadland E, Fausa O, Lygren I, et al. Incidence of Crohn's disease in four counties of southeastern Norway, 1990-93. A prospective population-based study. Scand J Gastroenterol 1996; 31:355-361.
8. Moum B, Ekbom A, Vatn MH, Aadland E, Sauar J, Lygren I, et al. Inflammatory bowel disease: re-evaluation of the diagnosis in a prospective population based study in south-eastern Norway. Gut 1997; 40:328-332.
9. Moum B, Ekbom A, Vatn MH, Aadland E, Sauar J, Lygren I, et al. Clinical course during the first year after diagnosis in ulcerative colitis and Crohn's disease. Results of a large prospective population-based study in southeastern Norway 1990-1993. Scand J Gastroenterol 1997; 32:1005-1012.
10. Mitchell A, Guyatt G, Singer J, (rvine EJ, Goodacre R, Tompkins C, et al. Quality of life in patients with inflammatory bowel disease. J Clin Gastroenterol 1988; 10:306-310.
11. Irvine EJ. Quality of life - measurement in inflammatory bowel disease. Scand J Gastroenterol 1993; 28 (suppl 199):36-39.
12. Martin F, Sutherland L, Beck IT, Anderson AH, Williams CN, Saibil F, et al. Oral 5ASA versus prednisone in short-term treatment of Crohn's disease: a multicentre controlled clinical trial. Can J Gastroenterol 1990; 4:452-457.
13. Feagan BG, Rochon J, Fedorak RN, Irvine EJ, Wild G, Sutherland L, et al. Methotrexate for the treatment of Crohn's disease. N Engl J Med 1995; 332:292-297.
14. Garrett JW, Drossmann DA. Health status in inflammatory bowel disease. Biological and behavioural considerations. Gastroenterology 1990; 99:240-246.
15. Hjortswang H, Aimer S, Strøm M. The network: a strategy to describe the relationship between quality of life and disease activity. The case of inflammatory bowel disease. Eur J Gastroenterol Hepatol 1999; 11:1099-1104.
16. Jahnsen J, Moum B, Schulz T, Sauar J, Lygren I, Stray N, et al. Inflammatory bowel disease, disease course and status 5 years after diagnosis (The IBSEN study). Gastroenterology 2000; 118:A1005.
17. Binder V, Both H, Hansen PK, Hendriksen C, Kreiner S, Torp-Pedersen K. Incidence and prevalence of ulcerative colitis and Crohn's disease in the county of Copenhagen, 1962 to 1978. Gastroenterology 1982; 83:563-568.
18. Bernklev T, Mourn B, Jahnsen J, and the Inflammatory Bowel South-Eastern Norway (IBSEN) Group of Gastroenterologists. Variables influencing health related quality of life in patients with inflammatory bowel disease. Gastroenterology 2003; 124 (suppl S):A210.
19. Martin A, Leone L, Fries W, Naccarato R. Quality of life in inflammatory bowel disease. Ital J Gastroenterol 1995; 27:450-454.
20. Pallis AG, Vlachonikolis IG, Mouzas IA. Quality of life of Greek patients with inflammatory bowel disease. Validation of the Greek translation of the Inflammatory Bowel Disease Questionnaire. Digestion 2001; 63:240-246.
21. de Boer AGEM, Wijker W, Bartelsman JFW, de Haes HCJM. Inflammatory Bowel Disease Questionnaire: cross-cultural adaptation and further validation. Eur J Gastroenterol Hepatol 1995; 7:1043-1050.
22. Russel MGVM, Pastoor CJ, Brandon S, Rijken J, Engels LGJB, van der Heijde DMFM, Stockbrügger RW. Validation of the Dutch translation of the Inflammatory Bowel Disease Questionnaire (IBDQ): a health-related quality of life questionnaire in inflammatory bowel disease. Digestion 1997; 58:282-288.
23. Cheung WY, Garratt AM, Russell IT, Williams JG. The UK IBDQ - a British version of the Inflammatory Bowel Disease Questionnaire: development and validation. J Clin Epidemiol 2000; 53:297-306.
24. Han SW, McColl E, Steen N, Barton JR, Welfare MR. The Inflammatory Bowel Disease Questionnaire: a valid and reliable measure in ulcerative colitis patients in the north-east of England. Scand J Gastroenterol 1998; 33:961-966.
25. Lopez-Vivancos J, Casellas F, Badia X, Vilaseca J, Malagelada JR. Validation of the Spanish version of the Inflammatory Bowel Disease Questionnaire on ulcerative colitis and Crohn's disease. Digestion 1999; 60:274-280.
26. Kim WH, Cho YS, Yoo HM, Park IS, Park EC, Lim JG. Quality of life in Korean patients with inflammatory bowel diseases: ulcerative colitis, Crohn's disease and intestinal Behcet's disease. Int J Colorec Dis 1999; 14:52-57.
27. Faubion WA, Loftus EV, Harmsen WS, Zinsmeister AR, Sandborn WJ. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 2001; 121:255-260.
28. Irvine EJ. Effects of budesonide therapy on quality of life in active Crohn's disease. Research and Clinical Forums 1996; 18:77-85.
29. Hjortswang H, Strom M, Almer S. Health-related quality of life in Swedish patients with ulcerative colitis. Am J Gastroenterol 1998; 93:2203-2211.
30. Bergquist U, Babic A. Aspects of certainty in patient classification using a health-related quality-of-life instrument in inflammatory bowel disease. Proc AMIA Symp 1999; 202-206.
31. Hjortswang H, Järnerot G, Curman B, Sandberg-Gertzén H, Tysk C, Bomberg B, et al. The influence of demographic and disease-related factors on health-related quality of life in patients with ulcerative colitis. Eur J Gastroenterol Hepatol 2003; 15:1011-1020.
32. Ware JE. SF-36 Health Survey. Manual and Interpretation Guide. The Health Institute, New England Medical Center; 1993.
33. Loge JH, Kaasa S. Short-Form 36 (SF-36) health survey: normative data from the general Norwegian population. Scand J Soc Med 1998; 26:250-258.